Brain Tumor Pathology

Top Research Topics at Brain Tumor Pathology?

Pathology, Neurosurgery, Immunohistochemistry, Glioma and Magnetic resonance imaging are among the topics commonly tackled in Brain Tumor Pathology. In addition to Pathology research, the journal aims to explore topics under IDH1, Radiation therapy and Anatomy. While Brain Tumor Pathology primarily focused on IDH1, it also opened dialogues on the discipline of Isocitrate dehydrogenase.

The journal explores topics in Neurosurgery which can be helpful for research in disciplines like Internal medicine, Pathological and Oncology. Brain Tumor Pathology focuses on Immunohistochemistry but the discussions also offer insight into other areas such as Staining, Molecular biology, Anaplastic astrocytoma and ATRX. While Glioma is the focus of the journal, it also provided insights into the studies of Mutation and Angiogenesis.

The in-depth study on Angiogenesis also explores topics in the intersecting field of Vascular endothelial growth factor. The Magnetic resonance imaging study featured in it draws connections with the study of Differential diagnosis. Oligodendroglioma research is concerned with Oligodendroglial Tumor in particular.

• Pathology (92.29%)
• Neurosurgery (24.60%)
• Immunohistochemistry (24.45%)

What are the most cited papers published in the journal?

• Angiogenesis and invasion in glioma. (177 citations)
• The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. (169 citations)
• Genetic profile of astrocytic and oligodendroglial gliomas (127 citations)

Research areas of the most cited articles at Brain Tumor Pathology:

The journal papers are mainly concerned with subjects like Pathology, Glioma, Immunohistochemistry, Neurosurgery and Cancer research. The most cited articles focus on Pathology but the discussions also offer insight into other areas such as Anaplastic astrocytoma and Magnetic resonance imaging. While the published papers focused on Glioma, they were also able to explore topics like Mutation, IDH1, Cancer cell and Angiogenesis.

What topics the last edition of the journal is best known for?

• Cancer
• Gene
• Internal medicine

The previous edition focused in particular on these issues:

Brain Tumor Pathology explores disciplines such as Pathology, Neurosurgery, Glioma, Immunohistochemistry and Central nervous system. The work on Pathology tackled in Brain Tumor Pathology brings together disciplines like Internal medicine, Diffuse Glioma, ATRX, Astrocytoma and Immunotherapy. The journal explores issues in Neurosurgery which can be linked to other research areas like Lesion, Primary central nervous system lymphoma, Chemotherapy, Pathological and Magnetic resonance imaging.

The studies on Glioma discussed can also contribute to research in the domains of PD-L1, Open biopsy and Combination therapy. It facilitates discussions on Immunohistochemistry that incorporate concepts from other fields like Thyroid Transcription Factor 1, Hemangiopericytoma, Real-time polymerase chain reaction and Copy-number variation. Internal tandem duplication, Who classification, Molecular heterogeneity, YWHAE and Neuroepithelial cell are some topics wherein Central nervous system research discussed in Brain Tumor Pathology have an impact.

The most cited articles from the last journal are:

• Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features (6 citations)
• Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas (3 citations)
• Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Brain Tumor Pathology (based on the number of publications) are:

• Yoichi Nakazato (25 papers) absent at the last edition,
• Sumihito Nobusawa (25 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• Teiji Tominaga (20 papers) published 1 paper at the last edition,
• Shinya Tanaka (19 papers) absent at the last edition,
• Hideaki Yokoo (17 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Brain Tumor Pathology (based on the number of publications) are:

• Gunma University (50 papers) published 5 papers at the last edition, 2 more than at the previous edition,
• Tohoku University (27 papers) published 1 paper at the last edition,
• Hokkaido University (25 papers) absent at the last edition,
• Keio University (22 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• University of Tsukuba (21 papers) published 1 paper at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.94% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 30.30% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.12% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.21% of all publications and 36.36% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Connected Research Fields

The fascinating field of Brain Tumor Pathology is not only standalone, but it is also interconnected with a range of other medical, biological and radiological fields. This makes the subject matter discussed within the journal applicable to a variety of academia, including researchers, practitioners, students, and professionals eager to deepen their knowledge base.

In line with the interdisciplinary nature of this field, the journal of Brain Tumor Pathology exhibits a similar behaviour. Its vibrant content finds resonance with a multitude of other subject areas, permitting interdisciplinary dialogue and cross-fertilization of ideas. Making critical connections between the research topics enhances the depth of understanding and broadens the horizons of innovation.

For instance, the in-depth discussions about Neurosurgery happening within the journal creates a potential connection for those studying similar topics in fields such as Internal Medicine or Oncology. The exploration of Immunohistochemistry adds to the knowledge bank of those intrigued by molecular biology or staining techniques.

Furthermore, in another thread, Glioma-related studies discussed in the journal offer valuable insights to the professionals working on mutation or angiogenesis. An intriguing interconnection also exists between the realms of angiogenesis and the vascular endothelial growth factor.

Research students pursuing specialty courses like lpn programs in new york may find these interspersed narratives deeply enlightening as they plot out their research paths. As such, staying updated with the discussions in the Brain Tumor Pathology opens up a spectrum of macabre, yet rewarding possibilities for continuing studies in this exciting and rapidly evolving field.